Skip to main content

Navigation group

Type at least 3 characters
1,205 articles

Articles

Original Research

Published on 14 Jul 2020

Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy

in Cardiovascular and Smooth Muscle Pharmacology

  • Leiliane Rodrigues Marcatto
  • Luciana Sacilotto
  • Letícia Camargo Tavares
  • Debora Stephanie Pereira Souza
  • Natália Olivetti
  • Celia Maria Cassaro Strunz
  • Francisco Carlos Costa Darrieux
  • Maurício Ibrahim Scanavacca
  • Jose Eduardo Krieger
  • Alexandre Costa Pereira
Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01056
  • 2,149 views
  • 1 citation

Original Research

Published on 03 Jul 2020

The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study

in Cardiovascular and Smooth Muscle Pharmacology

  • Hélène Haguet
  • Céline Bouvy
  • Anne-Sophie Delvigne
  • Elise Modaffari
  • Adeline Wannez
  • Pierre Sonveaux
  • Jean-Michel Dogné
  • Jonathan Douxfils
The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01007
  • 7,058 views
  • 24 citations